IPPRA / Grant Monitor

2026-11-05
← Board

FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

FDABAA-27-00123 · FOOD AND DRUG ADMINISTRATION · FDA OFFICE OF ACQ GRANT SVCS

biomedical clinical public health ai data science materials manufacturing

Closes
2027-02-01 · 88 d
Award ceiling
—
Award floor
—
Program funding
—
Expected awards
—
Cost sharing
No
Posted
2026-10-30
Instrument
—
Characterization · gpt-5.4-mini · 2026-10-31

FDA will fund extramural basic and applied research and development projects that advance regulatory science and innovation in topic areas defined in the BAA.

Funds
basic research
University
direct
social behavioral
minor
physical sciences
substantial
engineering
substantial
life biomedical
central
computational data
substantial

⚑ Federal contract/BAA vehicle rather than a standard grant. · Uses the term 'acquisition' and is governed by FAR 6.102(d)(2) and 35.016. · Specific research areas/subareas are defined inside the BAA; applicants must align with those scope areas. · No set-aside noted.

18 / 100 IPPRA team judgment

This is a broad FDA regulatory science BAA, but the listed scope is biomedical/clinical, AI/data science, and materials/manufacturing rather than the team’s core public-opinion, hazard-communication, energy, and education-policy lines. The team might contribute only tangentially on public health communication or survey methods, but this is not a plausible PI-level fit for anyone on the roster.

JUDGED AGAINST THE ROSTER'S PUBLICATION DOSSIER · GPT-5.4-MINI · 2026-10-31

Unit fits — one characterization, each unit's own rules

Physical Sciences & Engineering (demo) 80 strong technical depth: substantial; funds basic research
IPPRA 58 good peripheral portfolio topic: public_health; social/behavioral work is minor; funds basic research; biomedical core — IPPRA health lane is communication/crisis/policy (capped)
Tom Love Innovation Hub 30 weak prototyping/demonstration stage; deep-tech content

Description

In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement. FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.

Eligibility

Applicant restrictions (federal contract). Set-aside: No Set aside used. Notice type: Special Notice. Organization: HEALTH AND HUMAN SERVICES, DEPARTMENT OF / FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS.

Apply

View on Grants.gov →

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · HHS services agencies (SAMHSA / HRSA / CDC / ACF) conventions SEE AN HHS EXAMPLE →

Funder-faithful document skeletons — HHS services agencies (SAMHSA / HRSA / CDC / ACF)'s document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING